TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $50

Benzinga · 3d ago
TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $45 to $50.